Unit of Clinical Chemistry, Department of Medical Laboratory Science, University College Hospital, Ibadan, Nigeria.
Unit of Clinical Chemistry, Department of Medical Lab Science, Lead City University, Ibadan, Nigeria.
Clin Chem Lab Med. 2020 Sep 25;58(10):1645-1650. doi: 10.1515/cclm-2020-0748.
Severe Acute Respiratory Syndrome - novel Coronavirus 2 (SARS-nCoV-2), was first reported in Wuhan, China, in December, 2019. Since the outbreak, the virus has infected more than 9,866,685 individuals, 4,983,029 treated and discharged and 495,692 deaths globally. The first Coronavirus Disease 2019 (COVID-19) in Nigeria was imported in February, 2020 and since then community transmission has been prevalent. As at the time of writing this report, Nigeria has reported about 23,298 cases of COVID-19, 8,253 treated and discharged and 554 deaths, giving a case mortality ratio of 2.4%. While responsible government agencies and international partners have been working hard to curtail the spread of the disease, we present in this report, some matters arising from managing COVID-19 pandemic in Nigeria; and proffered suggestions which could help not only in managing the current COVID-19 pandemic, but also for winning future outbreaks of public health significance with a view to curtailing global health security.
严重急性呼吸系统综合症 - 新型冠状病毒 2(SARS-nCoV-2)于 2019 年 12 月在中国武汉首次报告。自疫情爆发以来,该病毒已在全球感染超过 9866685 人,4983029 人接受治疗并出院,495692 人死亡。尼日利亚首例 2019 年冠状病毒病(COVID-19)于 2020 年 2 月输入,此后社区传播一直很普遍。截至撰写本报告时,尼日利亚已报告约 23298 例 COVID-19 病例,8253 例接受治疗并出院,554 例死亡,病死率为 2.4%。虽然负责的政府机构和国际合作伙伴一直在努力遏制疾病的传播,但我们在本报告中提出了在尼日利亚管理 COVID-19 大流行中出现的一些问题,并提出了一些建议,这些建议不仅有助于管理当前的 COVID-19 大流行,还有助于赢得未来具有公共卫生意义的疫情爆发,以遏制全球卫生安全。